Illumina's Q3 Revenues Increase 14 Percent | GenomeWeb

This story has been modified to add management comments from Illumina's conference call.

NEW YORK (GenomeWeb) – Illumina reported after the close of the market Tuesday that its third quarter revenues increased 14 percent over the third quarter of 2014, consistent with the company's preliminary report earlier this month that revenues would not be as high as anticipated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.